‘An Act To Reduce Obesity by Reimbursing for Prescription Drug Therapy Provided by a Member of a Weight Management Team’
Amend the bill by striking out the title and substituting the following:
Amend the bill by striking out everything after the enacting clause and inserting the following:
‘Sec. 1. 22 MRSA §3174-BBB is enacted to read:
§ 3174-BBB. Prescription drug therapy for obesity; rules
The department shall provide for reimbursement under the MaineCare program for prescription drug therapy services to treat obesity that are provided by a physician licensed pursuant to Title 32, chapter 36 or 48, physician assistant licensed pursuant to Title 32, chapter 36 or 48 or nurse practitioner licensed pursuant to Title 32, chapter 31 who is part of a weight management team. Prescription drug therapy services may be provided in any office, facility or other setting in which the medical provider practices.
For purposes of this section, "weight management team" means a multidisciplinary group of providers who provide comprehensive weight management services to a patient, including, but not limited to, behavioral health services; medical nutrition therapy; physical activity, including but not limited to physical therapy, athletic training, or kinesiology; or specialized medical services, including but not limited to services related to endocrinology, diabetes, metabolism or bariatric surgery. A provider is not required to practice in the same setting as other members of the team to be considered part of a weight management team under this section. As used in this section, "medical nutrition therapy" means a therapeutic approach to treating obesity and its associated symptoms by use of counseling and a specifically tailored diet devised and monitored by a physician licensed pursuant to Title 32, chapter 36 or 48, a physician assistant licensed pursuant to Title 32, chapter 36 or 48, a dietitian licensed pursuant to Title 32, chapter 104 or a nurse practitioner licensed pursuant to Title 32, chapter 31.
The department shall adopt rules to implement this section. Rules adopted pursuant to this paragraph are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A.
Sec. 2. Appropriations and allocations. The following appropriations and allocations are made.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Medical Care - Payments to Providers 0147
Initiative: Provides appropriations and allocations for reimbursement under the MaineCare program for obesity treatment medication.
| GENERAL FUND | 2019-20 | 2020-21 |
|
All Other
|
$3,949,213 | $2,889,105 |
 |
|
|
| GENERAL FUND TOTAL | $3,949,213 | $2,889,105 |
| FEDERAL EXPENDITURES FUND | 2019-20 | 2020-21 |
|
All Other
|
$9,517,922 | $6,509,885 |
|
|
|
| FEDERAL EXPENDITURES FUND TOTAL | $9,517,922 | $6,509,885 |
| OTHER SPECIAL REVENUE FUNDS | 2019-20 | 2020-21 |
|
All Other
|
$1,882,036 | $5,018,761 |
|
|
|
| OTHER SPECIAL REVENUE FUNDS TOTAL | $1,882,036 | $5,018,761 |
Amend the bill by relettering or renumbering any nonconsecutive Part letter or section number to read consecutively.
summary
This amendment, which is the majority report of the committee, strikes the bill, which is a concept draft, to provide for reimbursement under the MaineCare program for prescription drug therapy services to treat obesity. The amendment also adds an appropriations and allocations section.
FISCAL NOTE REQUIRED
(See attached)